— PUBLICATIONS —

Liste des publications GINECO - Cancer Ovaire 2015

  • FAG3 – Article (Aging (Albany NY))
    C. Falandry
    Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study.
    Aging (Albany NY) - Décembre 2015 (réf. PubMed : PMID: 26638179 [PubMed - in process])
  • AURELIA – Article (The Lancet Oncology)
    A.M. Poveda
    Bevacizumab Combined with Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
    Journal of Clinical Oncology - Novembre 2015 (réf. PubMed : PMID: 26282651 [PubMed - indexed for MEDLINE])
  • VACOA – Article (The Lancet Oncology)
    Andreas du Bois
    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
    The Lancet Oncology - Novembre 2015 (réf. PubMed : PMID: 26590673 [PubMed - indexed for MEDLINE])
  • ICON7 – Article (The Lancet Oncology)
    A.M. Oza
    Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
    The Lancet Oncology - Août 2015 (réf. PubMed : PMID: 26115797 [PubMed - indexed for MEDLINE])
  • TARCEVA – Article (Targeted Oncology)
    E. Despierre
    Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
    Targeted Oncology - Mai 2015 (réf. PubMed : PMID: 26004768 [PubMed - as supplied by publisher])
  • EXPRESSION III – Article (Bulletin du cancer)
    L. De Cock
    Expectations of patients with ovarian cancer. Results of the European investigation EXPRESSION III in French patients from GINECO group
    Bulletin du cancer - Mars 2015 (réf. PubMed : PMID: 25749410 [PubMed - indexed for MEDLINE])
  • AGO-OVAR16 – Article (Gynecologic Oncology)
    A. Floquet
    Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.
    Gynecologic Oncology - Janvier 2015 (réf. PubMed : PMID: 25434635 [PubMed - indexed for MEDLINE])
  • CALYPSO – Article (European Journal of Cancer)
    S. Mahner
    Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
    European Journal of Cancer - Février 2015 (réf. PubMed : PMID: 25534295 [PubMed - indexed for MEDLINE])
  • CALYPSO – Article (Gynecologic Oncology)
    C.K. Lee
    Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial.
    Gynecologic Oncology - Janvier 2015 (réf. PubMed : PMID: 25281492 - DOI: 10.1016/j.ygyno.2014.09.017)
  • CALYPSO – Article (Gynecologic Oncology)
    C.K. Lee
    Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial.
    Gynecologic Oncology - Janvier 2015 (réf. PubMed : PMID: 25281492 [PubMed - indexed for MEDLINE])

Haut de page

Modifié le 30-06-2017 15:06